IVIG Versus Plasmapheresis in the Treatment of Guillian Barrie Syndrome Patients
Learn more about:
Related Clinical Trial
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Participants With Guillain-Barré Syndrome (GBS)
Effects of Proprioceptive Neuromuscular Training on Sensory and Motor Function in Guillain Barre Syndrome
RehabGBs: Rehabilitation in People With Guillain-Barré Syndrome
An Assistive Powered Wheelchair: Stage 2 Trial
Ultrasonography and Electrophysiology in GBS
Comparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre Syndrome
IVIG Versus Plasmapheresis in the Treatment of Guillian Barrie Syndrome Patients
Predictors and Prognostic Factors of Gullian Barrie Syndrome Outcome
A Phase 3 Study to Evaluate the Efficacy and Safety of Eculizumab in Guillain-Barré Syndrome
Efficacy and Safety of ANX005 in Subjects With Guillain-Barré Syndrome
Expression Profile of ERK5 and PKM2 Kinases in Neuroinflammatory Diseases.
Mini-pool Intravenous Immunoglobulin (MP-IVIG) in Guillain-Barré Syndrome
The Effectiveness and Safety of Human Lumbar Puncture Assist Device (LPat)
Feasibility of Two New Software Modules for the Rehabilitation of Patients With Neuromuscular Upper Limb Impairments
Biomarkers in Polyradiculoneuropathies
Brain Computer Interface for Communication in ICU: a Feasibility Study
Regional Citrate Anticoagulation in Plasma Exchange Treatment
Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre Syndrome
Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré Syndrome
Early Prediction of Respiratory and Autonomic Complications of GBS Using Neuromuscular Ultrasound
Early Mechanical Ventilation for Guillain Barré Syndrome
A Clinical Study of ANX005 and IVIG in Subjects With Guillain Barré Syndrome (GBS)
Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-aminopyridine
Efficacy and Safety Study of GB-0998 for Guillain-Barré Syndrome
Peripheral Nerve Ultrasound for Diagnosis and Prognosis of Guillain-Barre Syndrome
The Changes of Cytokines in Guillain Barré Syndrome: the Correlation With Clinical Manifestations and Skin Innervation
A Clinical Trial of CK0801 (a New Drug) In Patients With Treatment-Resistant Guillain-Barré Syndrome (GBS)
Small Volume Plasma Exchange (SVPE) for Guillain-Barré Syndrome (GBS) Patients
Safety Study of GBS Following Menactra Meningococcal Vaccination
sCD163 as a Potential Biomarker in Guillain- Barré Syndrome
Efficacy of Intravenous Gamma Globulin on Guillain-Barre Syndrome
Intravenous Immunoglobulin (IVIG) Versus Plasma Exchange (PE) for Ventilated Children With Guillain Barre Syndrome (GBS)
A Study of Imlifidase in Patients With Guillain-Barré Syndrome
Gastrointestinal Transit Time in Patients With Guillain-Barré Syndrome